CTLA4 and melanoma: The presence of TLS and active B cell infiltrates in the pre-treatment biopsies of melanoma, RCC, STS, and UC has been demonstrated to correlate with the response to PD-1 inhibition or the combination of PD-1 and CTLA-4 [64].